Effect of zinc supplementation in children with cystic fibrosis
Phase 3
- Conditions
- Health Condition 1: null- Children suffering from cystic fibrosis
- Registration Number
- CTRI/2011/12/002230
- Lead Sponsor
- Indian Council of Medical Reaserch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
Children above the age of 5 years of either sex with cystic fibrosis (diagnosis based on two abnormal sweat chloride of > 60 mEq/l on two occasions in children with clinical features suggestive of cystic fibrosis).
Exclusion Criteria
1.Children who are not willing to come for regular follow up.
2.Children who are on any zinc supplementation in last one month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Average days of systemic antibiotics in the two groups over one year.Timepoint: At enrolment and end of one year
- Secondary Outcome Measures
Name Time Method 1.Difference in FEV1 at 3, 6, 9 and 12 months in children above 5 years of age as measured by spirometry <br/ ><br>2.Difference in colonization of airways with pseudomonas at 3, 6, 9 and 12 months <br/ ><br> <br/ ><br>Timepoint: At enrolment (Base line), 3, 6, 9 and 12 months